A Phase 2, Randomized, Double-Blind, Placebo Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects with Primary Sclerosing Cholangitis Without Cirrhosis

The requested reference [3567e7619771b94723c468ff3141a96cf0724205] no longer exists in our database. It has been replaced by the current reference: [3277bf5611a7b919fcffc25c6021296de1d23801]

Authors
Category Primary study
Registry of TrialsEU Clinical Trials Register
Year 2016
This article has no abstract
Epistemonikos ID: 1370f4fdf93523ec84ea3b48b650d287503c91e3
First added on: Jan 23, 2025